Chronic opioid use during pregnancy: maternal and fetal implications.
Clin Perinatol
; 40(3): 337-50, 2013 Sep.
Article
en En
| MEDLINE
| ID: mdl-23972743
ABSTRACT
Current trends in the United States suggest that chronic narcotic use has increased in reproductive aged women over the past 10 years. Regular exposure to such substances during pregnancy has maternal and fetal implications. Appropriate prenatal care is critical to optimizing outcomes. Management options for narcotic dependence should be patient-specific and may include discontinuation of narcotics with careful observation, limitation of prescription dispensing, or substitution therapy with methadone or buprenorphine. A multidisciplinary, collaborative approach is highly recommended. This review discusses usage of narcotic medications, associated maternal and fetal risks, and management strategies for the antepartum, intrapartum, and postpartum periods.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Complicaciones del Embarazo
/
Síndrome de Abstinencia Neonatal
/
Tratamiento de Sustitución de Opiáceos
/
Analgésicos Opioides
/
Trastornos Relacionados con Opioides
Límite:
Female
/
Humans
/
Newborn
/
Pregnancy
Idioma:
En
Revista:
Clin Perinatol
Año:
2013
Tipo del documento:
Article
País de afiliación:
Estados Unidos